Integrated Advisors Network LLC Invests $165,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Integrated Advisors Network LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 18,387 shares of the pharmacy operator’s stock, valued at approximately $165,000.

Several other large investors also recently bought and sold shares of the business. First Trust Direct Indexing L.P. boosted its holdings in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after acquiring an additional 597 shares during the last quarter. FinTrust Capital Advisors LLC grew its position in Walgreens Boots Alliance by 60.4% in the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 802 shares during the period. Redwood Investment Management LLC raised its stake in Walgreens Boots Alliance by 0.9% during the 1st quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after buying an additional 850 shares during the last quarter. Empirical Finance LLC lifted its holdings in shares of Walgreens Boots Alliance by 3.5% during the 1st quarter. Empirical Finance LLC now owns 26,093 shares of the pharmacy operator’s stock valued at $566,000 after buying an additional 888 shares during the period. Finally, Inlet Private Wealth LLC boosted its stake in shares of Walgreens Boots Alliance by 1.9% in the 2nd quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after buying an additional 900 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $9.46 on Friday. The stock has a 50-day moving average price of $9.20 and a 200 day moving average price of $12.51. The stock has a market capitalization of $8.18 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.20 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter last year, the business posted $0.67 earnings per share. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.54 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.57%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. UBS Group raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Finally, Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.